genO-hPD-1 Humanized Mouse

The genO‑hPD‑1 mouse enables the in vivo efficacy assessment and profiling of compounds targeting the human immune checkpoint PD-1 in fully immunocompetent mice

  Application Areas: 

Model No.NomenclatureGenotype
23512-MC57BL/6N-Pdcd1tm1.1(PDCD1)Genohu/hu
23512-FC57BL/6N-Pdcd1tm1.1(PDCD1)Genohu/hu

Availability Notice: genOway target-specific humanized models are available from Taconic exclusively for U.S.-based customers.


Evaluate a New Humanized Model with Special Pilot Cohort Pricing

Considering a target-specific humanized mouse model for your next study? Special pilot cohort pricing makes it easier to evaluate a new model in your experimental setting before incorporating it into a broader program study.

For-profit customers can save 30-60% on your first cohort of an eligible genOway model, with an additional 20% discount available for mixed-sex cohorts.

View:
Select One

Overview

Nomenclature: C57BL/6N-Pdcd1tm1.1(PDCD1)Geno

Applications: Assess PD-1-targeting compound efficacy; perform tumor-growth inhibition assays with mono- or combination therapy; evaluate PD-1 agonists for autoimmune/inflammatory conditions; investigate mechanism of action and therapeutic benefits.

Features: Physiological regulation and expression of humanized PD-1; no murine target-gene expression; fully functional mouse immune system; model available on C57BL/6 and BALB/c backgrounds.

Origin

This model was generated by genOway S.A.

Orders by weight: Taconic cannot accept orders by weight for this model. Please note that shipments may contain animals with a larger weight variation. 

Genetics

Species: Mouse
Strain Type: Inbred
Allele Type: Genetically Humanized
Coat Color: Black
Genetic Background: C57BL/6N

Guides & Publications

Initial Publication:

  • Chan S, Belmar N, Ho S, Rogers B, Stickler M, Graham M, Lee E, Tran N, Zhang D, Gupta P, Sho M, MacDonough T, Woolley A, Kim H, Zhang H, Liu W, Zheng P, Dezso Z, Halliwill K, Ceccarelli M, Rhodes S, Thakur A, Forsyth CM, Xiong M, Tan SS, Iyer R, Lake M, Digiammarino E, Zhou L, Bigelow L, Longenecker K, Judge RA, Liu C, Trumble M, Remis JP, Fox M, Cairns B, Akamatsu Y, Hollenbaugh D, Harding F, Alvarez HM. An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy. Nat Cancer. 2022 Mar;3(3):337-354.

Applications & Therapeutic Areas

  • Oncology & Immuno-Oncology
  • Immunology

Transit, Housing & Welfare

Need more info? Click the live chat button or Contact Us

Licensing

Click here to download the General Conditions of Sale for genOway models.

View the production locations(s) and the accompanying current IHMS™ Health Report and Taconic Health Standard for this model

Schedule A Scientific Consultation

Connect directly with a member of our Scientific Solutions team who can help you select the most appropriate model and maximize your experimental success.

Related Models

Click here to view related models.

Oncology & Immuno-Oncology Portfolio

Target-Specific Humanized Mice

Explore target-specific genOway humanized mouse models available through Taconic for oncology drug discovery and translational research in the United States.

Collaborate with Us to Advance Your Immuno-Oncology Research